Загрузка...
No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction
BACKGROUND: Ticagrelor use during acute coronary syndromes demonstrated a decrease in all‐cause mortality in the PLATO (Platelet Inhibition and Patient Outcomes) trial. This effect has been attributed to a non–platelet‐derived improvement in endothelial function. The aim of this study was to determi...
Сохранить в:
| Опубликовано в: : | J Am Heart Assoc |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6404906/ https://ncbi.nlm.nih.gov/pubmed/30371302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009444 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|